Kelly, W. K., O’Connor, O. A., Lee Krug, M., Chiao, J. H., Heaney, M., Curley, T., . . . Richon, V. M. (2005). Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer.
Chicago Style CitationKelly, William Kevin, et al. Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer. 2005.
Cita MLAKelly, William Kevin, et al. Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer. 2005.
Atenció: Aquestes cites poden no estar 100% correctes.